Clinical significance of evaluating primary lesions in patients with gastric cancer who receive chem...
Clinical significance of evaluating primary lesions in patients with gastric cancer who receive chemotherapy
About this item
Full title
Author / Creator
Publisher
Japan: Japan : Springer Japan
Journal title
Language
English
Formats
Publication information
Publisher
Japan: Japan : Springer Japan
Subjects
More information
Scope and Contents
Contents
Background In Western countries, the response of gastric cancer to chemotherapy is evaluated by assessing measurable metastatic lesions (MMLs) according to the response evaluation criteria in solid tumors (RECIST). In Japan, the response of primary lesions is assessed according to local Japanese criteria. We compared the response to chemotherapy as...
Alternative Titles
Full title
Clinical significance of evaluating primary lesions in patients with gastric cancer who receive chemotherapy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_733858967
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_733858967
Other Identifiers
ISSN
1436-3291
E-ISSN
1436-3305
DOI
10.1007/s10120-009-0533-8
